Asian doctor replenished rows of dollar billionaires due to vaccination from coronavirus. As Bloomberg writes, the shares of the Singapore company Raffles Medical Group, where Chun Yong Lu is the chief executive officer, took off 104 percent from March 2020.
According to analyst estimates, the net profit of a private health care provider has grown almost twice in the first half of 2021 and amounted to $ 27.8 million, while revenues became more than 42 percent and reached $ 343.8 million. The share of Chun Yong Lu, at the same time, estimated at 1.1 billion dollars – he and his family owns 52 percent of the company.
Raffles Medical manages 15 vaccination centers in Singapore and helps with coronavirus tests on the border, at airports and public events – so the company has adapted to the conditions of the pandemic. Many network services Medclinite have become unpopular – for example, because of the fear of becoming infected. People began to attend institutions for simple medical examinations.
Singapore accelerated the Vaccination rates from COVID-19 in the hope of September 80 percent of the population and start restoring tourism – one of the main economy for it. From January 2021, Raffles Medical joined the fight against the virus and sent its employees to take and handle the strokes to Coronavirus at testing points.
However, an analyst from CGS-CIMB Securities vi Cuang Tai warned that after a pandemic COVID-19, the company could become less profitable. Nevertheless, Chun Yong Lou of this is not afraid – he assesses his success not in money. “I do not measure our contribution to the market capitalization or price of stock. Raffles Medical carefully takes care of patients – that’s what is really important,” the 72-year-old former doctor admitted.
Chun Yong Lo and his friend Alfred Lo founded Raffles Medical in 1976. At first they combined two clinics, and now the network in Singapore has grown to 60 branches. In addition, Raffles Medical provides medical services in China, Japan and Cambodia.
recently became a billionaire and another Asian former doctor. Unlike Chun Yong Lu, the son-Gun did not continue his career in medicine. Korean businessman founded Fintech Startap Viva Republica, which at round financing attracted more than $ 40 million from investors and made an entrepreneur owner of a share of 1.2 billion dollars.
And in Russia, tens of billions of rubles on vaccines earned pharmaceutical companies, which are engaged in the production of Vaccine “V”. Most of this money (82 percent) got the company “Farmstandard” Billionaire Viktor Harchonin. The company has released almost 60 percent of the drug and earned 33.3 billion rubles.